Physician

Fariba Amani, MD

According to 2025 Medicare claims, Fariba Amani, MD (NPI: 1265656417) practices cardiac electrophysiology in the Merced, CA market, with the plurality of this provider's patient population coming from Merced, CA. This provider's primary affiliated billing organization is CENTRAL VALLEY CARDIOVASCULAR MEDICAL GROUP, INC (NPI: 1962750224; TIN: 010961637) and primary practice location at 95380-7507.

Amani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,363 traditional Medicare patients, billed 8,391 HCPCS/CPT codes, and received $628,885 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 3,841 prescription claims across 610 beneficiaries totaling $750,546 in drug costs, led by Eliquis (Apixaban). DME data shows 30 claims. Open Payments data shows 95 records totaling $3,483. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $57,373 to $750,546. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,964 and ending at $8,952.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,268	7,297	$433,529
2016	1,495	6,750	$492,294
2017	2,086	7,952	$487,834
2018	1,654	7,422	$494,732
2019	1,913	8,660	$615,458
2020	1,683	8,425	$630,294
2021	1,686	9,143	$694,498
2022	1,221	8,538	$559,034
2023	1,428	7,980	$563,370
2024	1,363	8,391	$628,885

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	216	1,205	$57,373
2016	312	1,867	$101,414
2017	369	2,386	$160,680
2018	459	3,043	$283,891
2019	509	3,592	$443,021
2020	513	4,015	$592,499
2021	560	4,517	$714,768
2022	546	4,163	$686,217
2023	578	4,304	$729,356
2024	610	3,841	$750,546

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	21	$1,500
2016	N/R	13	$363
2017	N/R	13	$394
2018	N/R	77	$1,267
2019	N/R	51	$858
2020	N/R	74	$2,483
2021	N/R	24	$420
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	30	$7,579

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	549	622	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	500	878	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	504	751	$67
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	675	928	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	443	584	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	276	16,935	$321,945
Xarelto	Rivaroxaban	159	10,895	$203,577
Entresto	Sacubitril/Valsartan	82	4,995	$100,432
Repatha Sureclick	Evolocumab	62	2,311	$44,914
Brilinta	Ticagrelor	15	840	$11,866

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0680	Non-pneumatic compression controller with sequential calibrated gradient pressure	Y	N/R	15	$7,089
E0679	Non-pneumatic sequential compression garment, half leg	Y	N/R	15	$490

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	95	$3,483	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Fariba Amani, MD?

Tedicare shows public-source Medicare data for Fariba Amani, MD (NPI 1265656417), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fariba Amani, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Fariba Amani, MD?

Fariba Amani, MD is linked to CENTRAL VALLEY CARDIOVASCULAR MEDICAL GROUP, INC (billing NPI 1962750224) in the available physician profile data.

Does Fariba Amani, MD have Open Payments data?

Fariba Amani, MD has 95 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.